Erwinase: Clinical Trials

4 trials of Erwinase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 2 recruiting. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Active not recruiting 2, Recruiting 2

Follow Erwinase: new trials by email Literature Review of Erwinase trials Research Report on Erwinase

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Allogeneic Hematopoietic Stem Cell Transplantation, Asparaginase Erwinia chrysanthemi, Biospecimen Collection - Acute Myeloid Leukemia
Phase 3RecruitingChildren's Oncology Group14002020-07-212026-09-17
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
Asparaginase Erwinia chrysanthemi, Blinatumomab, Cyclophosphamide - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3Active not recruitingNational Cancer Institute (NCI)67202019-07-032026-11-12
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Blinatumomab, Bortezomib, Cyclophosphamide - Acute Lymphoblastic Leukemia, Pediatric
Phase 3RecruitingMartin Schrappe50002018-07-152025-04-06
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Asparaginase, Asparaginase Erwinia chrysanthemi, Cytarabine - Acute Myeloid Leukemia, Down Syndrome
Phase 3Active not recruitingChildren's Oncology Group2802015-12-232026-08-19

Conditions studied

Down Syndrome (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Burkitt Lymphoma (1)  ·  Myelodysplastic Syndromes (1)  ·  Myeloproliferative Disorders (1)  ·  Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

Children's Oncology Group (2)  ·  Martin Schrappe (1)  ·  National Cancer Institute (NCI) (1)

Countries

Australia (4)  ·  Canada (3)  ·  Puerto Rico (3)  ·  United States (3)  ·  New Zealand (2)  ·  Austria (1)  ·  Czechia (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Saudi Arabia (1)  ·  Slovakia (1)  ·  Switzerland (1)

Top investigators

Jason N Berman (1)  ·  Martin Schrappe, MD (1)  ·  Sumit Gupta (1)  ·  Todd M Cooper (1)

Results publications

PMID 33843815, PMID 33844429, PMID 35129146, PMID 38107263, PMID 38841802, PMID 38947228, PMID 39651791, PMID 41124669, PMID 41671463, PMID 42497367, PMID 42748428

NIH funding

U10CA180886 (3)